Top Markets
Coin of the day
Palvella Therapeutics, Inc. Palvella Therapeutics, Inc.

Palvella Therapeutics, Inc.

PVLA
Classement en actions #6151
Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company... Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments for patients afflicted with severe and uncommon inherited skin conditions. Central to its pipeline is QTORIN 3.9% rapamycin anhydrous gel (referred to as QTORIN rapamycin), which is currently undergoing Phase 3 clinical trials for microcystic lymphatic malformations. Additionally, this drug is in Phase 2 evaluation for treating cutaneous venous malformations. Beyond these specific indications, Palvella is also advancing QTORIN rapamycin for the treatment of other dermatological diseases driven by the mTOR pathway. The company's headquarters are situated in Wayne, Pennsylvania.
Prix de l'action
$153.93
Capitalisation boursière
$2.21B
Changement (1 jour)
-0.26%
Changement (1 an)
172.68%
Pays
US
Échange Palvella Therapeutics, Inc. (PVLA)

Catégorie

Historique des divisions d’actions pour Palvella Therapeutics, Inc. (PVLA)
L’action Palvella Therapeutics, Inc. (symbole : PVLA) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Aug 27, 2026.
Une action PVLA achetée avant le Aug 27, 2026 équivaudrait aujourd’hui à 0 actions PVLA.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
Pas assez de données pour les dates fournies.
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH